4 research outputs found

    āļāļēāļĢāļžāļ’āļą āļ™āļēāđ€āļ„āļĢāļ·āļ­āļ‚āđˆāļēāļĒāļšāļĢāļīāļāļēāļĢāļŠāļļāļ‚āļ āļēāļžāļŠāļļāļĄāļŠāļ™āļŠāļģāļŦāļĢāļšāļą āļœāļđāđ‰āļ›āđˆ āļ§āļĒāđ€āļšāļēāļŦāļ§āļēāļ™āļ‚āļ­āļ‡āđ‚āļĢāļ‡āļžāļĒāļēāļšāļēāļĨāđ‚āļžāļ˜āļēāļĢāļēāļĄ

    Get PDF
    AbstractObjectives: This quasi-experimental study aimed to develop the primarycare network model of Photharam hospital. Method: The patients weredivided into control group (n = 48) receiving regular service at the hospitaland treatment group (n = 50) receiving services at the Primary Care Unit(PCU). Clinical outcome of stable patients at baseline and after 6 monthswere compared and healthcare providers’ and patients’ satisfaction wereobtained during the period from November 4, 2009 to August 15, 2010.Data collection was performed using clinical data and questionnaire. Thepercentage and mean were calculated and independent t-test wasperformed.Results: The differences in fasting blood sugar, hemoglobinA1c, systolic blood pressure and diastolic blood pressure, cholesterol,triglyceride, low density lipid and high density lipid level between the twogroups were not statistically significant at P = 0.05. Most patients (95.5%)were very satisfied with overall services. They reasoned that PCU serviceswere faster and more convenient than those at the hospital whilemaintaining similar level of disease control. Acceptability among PCUpatients was high and most patients (95.5%) agreed to continue to receivecare at the PCU. Healthcare providers were also satisfied with providingcare at PCU since this would be a direct benefit for the patients.Conclusion: Healthcare services for diabetic patients at the PCU were aseffective as those at the hospital. A primary care network service was oneof the models for developing quality services for diabetic patients.Keywords: primary care network, diabetes mellitus, effectiveness,satisfactionāļšāļ—āļ„āļąāļ”āļĒāđˆāļ­āļ§āļąāļ•āļ–āļļāļ›āļĢāļ°āļŠāļ‡āļ„āđŒ: āļāļēāļĢāļĻāļķāļāļĐāļēāļāļķāđˆāļ‡āļ—āļ”āļĨāļ­āļ‡āđ€āļžāļ·āđˆāļ­āļžāļąāļ’āļ™āļēāđ€āļ„āļĢāļ·āļ­āļ‚āđˆāļēāļĒāļšāļĢāļīāļāļēāļĢāļŠāļģāļŦāļĢāļąāļšāļœāļđāđ‰āļ›āđˆāļ§āļĒāđ€āļšāļēāļŦāļ§āļēāļ™āļ‚āļ­āļ‡āđ‚āļĢāļ‡āļžāļĒāļēāļšāļēāļĨāđ‚āļžāļ˜āļēāļĢāļēāļĄ āļ—āļĩāđˆāļĒāļąāļ‡āļ„āļ‡āđ„āļ§āđ‰āļ‹āļķāđˆāļ‡āļ„āļļāļ“āļ āļēāļžāđƒāļ™āļāļēāļĢāļĢāļąāļāļĐāļēāđāļĨāļ°āļ„āļ§āļēāļĄāļžāļķāļ‡āļžāļ­āđƒāļˆāļ‚āļ­āļ‡āļœāļđāđ‰āđƒāļŦāđ‰āđāļĨāļ°āļœāļđāđ‰āļĢāļąāļšāļšāļĢāļīāļāļēāļĢ āļ§āļīāļ˜āļĩāļāļēāļĢāļĻāļķāļāļĐāļē: āđ‚āļ”āļĒāđ€āļ›āļĢāļĩāļĒāļšāđ€āļ—āļĩāļĒāļšāļœāļĨāļ—āļēāļ‡āļ„āļĨāļīāļ™āļīāļāļ‚āļ­āļ‡āļœāļđāđ‰āļ›āđˆāļ§āļĒāļ—āļĩāđˆāļĄāļĩāļŠāļ āļēāļ§āļ°āļ„āļ‡āļ—āļĩāđˆāļāđˆāļ­āļ™āđāļĨāļ°āļ āļēāļĒāļŦāļĨāļąāļ‡ 6 āđ€āļ”āļ·āļ­āļ™ āļĻāļķāļāļĐāļēāļ„āļ§āļēāļĄāļžāļķāļ‡āļžāļ­āđƒāļˆāļ‚āļ­āļ‡āļœāļđāđ‰āđƒāļŦāđ‰āļšāļĢāļīāļāļēāļĢāđāļĨāļ°āļœāļđāđ‰āļ›āđˆāļ§āļĒ āļĢāļ°āļŦāļ§āđˆāļēāļ‡āļ§āļąāļ™āļ—āļĩāđˆ 4 āļžāļĪāļĻāļˆāļīāļāļēāļĒāļ™ 2552 āļ–āļķāļ‡ 28 āļāļĢāļāļŽāļēāļ„āļĄ 2553 āđ€āļāđ‡āļšāļĢāļ§āļšāļĢāļ§āļĄāļ‚āđ‰āļ­āļĄāļđāļĨāļ”āđ‰āļ§āļĒāđāļšāļšāļšāļąāļ™āļ—āļķāļ āđāļšāļšāļŠāļąāļĄāļ āļēāļĐāļ“āđŒāđāļĨāļ°āđāļšāļšāļŠāļ­āļšāļ–āļēāļĄ āđāļšāđˆāļ‡āļœāļđāđ‰āļ›āđˆāļ§āļĒāđ€āļ›āđ‡āļ™āļāļĨāļļāđˆāļĄāļ„āļ§āļšāļ„āļļāļĄāļˆāļģāļ™āļ§āļ™ 50 āļ„āļ™ āļ‹āļķāđˆāļ‡āļĢāļąāļšāļšāļĢāļīāļāļēāļĢāļ—āļĩāđˆāļ„āļĨāļīāļ™āļīāļāđ€āļšāļēāļŦāļ§āļēāļ™ āđ‚āļĢāļ‡āļžāļĒāļēāļšāļēāļĨāđ‚āļžāļ˜āļēāļĢāļēāļĄ āđāļĨāļ°āļāļĨāļļāđˆāļĄāļ—āļ”āļĨāļ­āļ‡āļˆāļģāļ™āļ§āļ™ 48 āļ„āļ™ āļ‹āļķāđˆāļ‡āļĢāļąāļšāļšāļĢāļīāļāļēāļĢāļ—āļĩāđˆāļĻāļđāļ™āļĒāđŒāļŠāļļāļ‚āļ āļēāļžāļŠāļļāļĄāļŠāļ™ āļ§āļīāđ€āļ„āļĢāļēāļ°āļŦāđŒāļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļēāļ‡āļŠāļ–āļīāļ•āļīāđ‚āļ”āļĒāđƒāļŠāđ‰āļ„āđˆāļēāļĢāđ‰āļ­āļĒāļĨāļ° āļ„āđˆāļēāđ€āļ‰āļĨāļĩāđˆāļĒ āđāļĨāļ° t-test āļœāļĨāļāļēāļĢāļĻāļķāļāļĐāļē: āļžāļšāļ§āđˆāļēāļĢāļ°āļ”āļąāļšāļ™āđ‰āļģāļ•āļēāļĨāļ‚āļ­āļ‡āļœāļđāđ‰āļ›āđˆāļ§āļĒāļ‚āļ“āļ°āļ­āļ”āļ­āļēāļŦāļēāļĢ āļŪāļĩāđ‚āļĄāđ‚āļāļĨāļšāļīāļ™āđ€āļ­āļ§āļąāļ™āļ‹āļĩ āļ„āļ§āļēāļĄāļ”āļąāļ™āđ‚āļĨāļŦāļīāļ•āļ•āļąāļ§āļšāļ™āđāļĨāļ°āļ•āļąāļ§āļĨāđˆāļēāļ‡ āļ„āļĨāļ­āđ€āļĢāļŠāđ€āļ•āļ­āļĢāļ­āļĨ āđ„āļ•āļĢāļāļĨāļĩāđ€āļ‹āļ­āđ„āļĢāļ”āđŒ āđ€āļ­āļŠāļ”āļĩāđāļ­āļĨ āđāļĨāļ°āđāļ­āļĨāļ”āļĩāđāļ­āļĨ āļ‚āļ­āļ‡āļœāļđāđ‰āļ›āđˆāļ§āļĒāļ—āļąāđ‰āļ‡ 2 āļāļĨāļļāđˆāļĄāđ„āļĄāđˆāđāļ•āļāļ•āđˆāļēāļ‡āļāļąāļ™āļ—āļĩāđˆāļĢāļ°āļ”āļąāļšāļ™āļąāļĒāļŠāļģāļ„āļąāļ 0.05 āļœāļđāđ‰āļ›āđˆāļ§āļĒāđ€āļāļ·āļ­āļšāļ—āļąāļ‡āđ‰ āļŦāļĄāļ” (91.3%) āļžāļķāļ‡āļžāļ­āđƒāļˆāļ•āđˆāļ­āļšāļĢāļīāļāļēāļĢāđ‚āļ”āļĒāļĢāļ§āļĄāđāļĨāļ°āđ€āļŦāđ‡āļ™āļ§āđˆāļēāļšāļĢāļīāļāļēāļĢāļ—āļĩāđˆāļĻāļđāļ™āļĒāđŒāļŠāļļāļ‚āļ āļēāļžāļŠāļļāļĄāļŠāļ™āļŠāļ°āļ”āļ§āļāđāļĨāļ°āļĢāļ§āļ”āđ€āļĢāđ‡āļ§āļāļ§āđˆāļēāļ—āļĩāđˆāđ‚āļĢāļ‡āļžāļĒāļēāļšāļēāļĨ āļ‚āļ“āļ°āļ—āļĩāđˆāļāļēāļĢāļ„āļ§āļšāļ„āļļāļĄāļŠāļ āļēāļ§āļ°āđ‚āļĢāļ„āļ‚āļ­āļ‡āļœāļđāđ‰āļ›āđˆāļ§āļĒāđ„āļĄāđˆāđāļ•āļāļ•āđˆāļēāļ‡āļāļąāļ™ āđāļĨāļ°āļœāļđāđ‰āļ›āđˆāļ§āļĒāđ€āļāļ·āļ­āļšāļ—āļąāđ‰āļ‡āļŦāļĄāļ” (95.5%) āļ­āļĒāļēāļāđ€āļ‚āđ‰āļēāļĢāđˆāļ§āļĄāđ‚āļ„āļĢāļ‡āļāļēāļĢāļ•āđˆāļ­āđ„āļ› āļŠāđˆāļ§āļ™āļœāļđāđ‰āđƒāļŦāđ‰āļšāļĢāļīāļāļēāļĢāļžāļķāļ‡āļžāļ­āđƒāļˆāļ•āđˆāļ­āđ‚āļ„āļĢāļ‡āļāļēāļĢāđ€āļŠāđˆāļ™āļāļąāļ™āđāļĨāļ°āđ€āļŦāđ‡āļ™āļ§āđˆāļēāđ€āļ›āđ‡āļ™āļ›āļĢāļ°āđ‚āļĒāļŠāļ™āđŒāđ‚āļ”āļĒāļ•āļĢāļ‡āļ•āđˆāļ­āļœāļđāđ‰āļ›āđˆāļ§āļĒ āļŠāļĢāļļāļ›: āļāļēāļĢāļĻāļķāļāļĐāļēāļ™āļĩāđ‰āđāļŠāļ”āļ‡āđƒāļŦāđ‰āđ€āļŦāđ‡āļ™āļ§āđˆāļēāđ„āļĄāđˆāļĄāļĩāļ„āļ§āļēāļĄāđāļ•āļāļ•āđˆāļēāļ‡āļ­āļĒāđˆāļēāļ‡āļĄāļĩāļ™āļąāļĒāļŠāļ–āļīāļ•āļīāļ‚āļ­āļ‡āļ›āļĢāļ°āļŠāļīāļ—āļ˜āļīāļœāļĨāđƒāļ™āļāļēāļĢāļ”āļđāđāļĨāļœāļđāđ‰āļ›āđˆāļ§āļĒāđ€āļšāļēāļŦāļ§āļēāļ™āļĢāļ°āļŦāļ§āđˆāļēāļ‡āļĻāļđāļ™āļĒāđŒāļŠāļļāļ‚āļ āļēāļžāļŠāļļāļĄāļŠāļ™āļāļąāļšāļ„āļĨāļīāļ™āļīāļāđ€āļšāļēāļŦāļ§āļēāļ™āļ‚āļ­āļ‡āđ‚āļĢāļ‡āļžāļĒāļēāļšāļēāļĨāļœāļđāđ‰āļĢāļąāļšāļšāļĢāļīāļāļēāļĢāđāļĨāļ°āļœāļđāđ‰āđƒāļŦāđ‰āļšāļĢāļīāļāļēāļĢāļĄāļĩāļ„āļ§āļēāļĄāļžāļķāļ‡āļžāļ­āđƒāļˆāđƒāļ™āļĢāļđāļ›āđāļšāļšāļšāļĢāļīāļāļēāļĢāļ—āļĩāđˆāļžāļąāļ’āļ™āļēāļ‚āļķāđ‰āļ™ āļ”āļąāļ‡āļ™āļąāđ‰āļ™āđ€āļ„āļĢāļ·āļ­āļ‚āđˆāļēāļĒāļšāļĢāļīāļāļēāļĢāļŠāļļāļ‚āļ āļēāļžāļŠāļļāļĄāļŠāļ™āđ€āļ›āđ‡āļ™āļĢāļđāļ›āđāļšāļšāļŦāļ™āļķāđˆāļ‡āļ‚āļ­āļ‡āļāļēāļĢāļžāļąāļ’āļ™āļēāļ„āļļāļ“āļ āļēāļžāļšāļĢāļīāļāļēāļĢāđƒāļ™āļāļēāļĢāļ”āļđāđāļĨāļœāļđāđ‰āļ›āđˆāļ§āļĒāđ€āļšāļēāļŦāļ§āļēāļ™āļ‚āļ­āļ‡āđ‚āļĢāļ‡āļžāļĒāļēāļšāļēāļĨāļ„āļģāļŠāļģāļ„āļąāļ: āđ€āļ„āļĢāļ·āļ­āļ‚āđˆāļēāļĒāļšāļĢāļīāļāļēāļĢāļŠāļļāļ‚āļ āļēāļžāļŠāļļāļĄāļŠāļ™, āđ€āļšāļēāļŦāļ§āļēāļ™, āļ›āļĢāļ°āļŠāļīāļ—āļ˜āļīāļœāļĨ, āļ„āļ§āļēāļĄāļžāļķāļ‡āļžāļ­āđƒ

    Can knowledgeable experts assess costs and outcomes as if they were ignorant? : An experiment within precision medicine evaluation

    Get PDF
    Objectives The purpose of this study is to evaluate the validity of the standard approach in expert judgment for evaluating precision medicines, in which experts are required to estimate outcomes as if they did not have access to diagnostic information, whereas in fact, they do. Methods Fourteen clinicians participated in an expert judgment task to estimate the cost and medical outcomes of the use of exome sequencing in pediatric patients with intractable epilepsy in Thailand. Experts were randomly assigned to either an “unblind” or “blind” group; the former was provided with the exome sequencing results for each patient case prior to the judgment task, whereas the latter was not provided with the exome sequencing results. Both groups were asked to estimate the outcomes for the counterfactual scenario, in which patients had not been tested by exome sequencing. Results Our study did not show significant results, possibly due to the small sample size of both participants and case studies. Conclusions A comparison of the unblind and blind approach did not show conclusive evidence that there is a difference in outcomes. However, until further evidence suggests otherwise, we recommend the blind approach as preferable when using expert judgment to evaluate precision medicines because this approach is more representative of the counterfactual scenario than the unblind approach

    The health utility of Graves' disease treatments at Damnoensaduak hospital

    No full text
    The objectives of this cross-sectional study were to compare the utility of anti-thyroid drug and radioactive iodine in patients  with Graves' disease (GD) at Damnoensaduak hospital, Ratchaburi, Thailand. This study included all patients who were diagnosed with Graves' disease during September 1, 2011 to January 31, 2012. There were 114 patients with Graves' disease in whom 80 patients were treated with anti-thyroid drug and 34 patients were treated with radioactive iodine. The utility was measured by using the EuroQol (EQ-5D) in Thai version. The health utility of  patients treated with anti-thyroid drug or radioactive iodine were compared by using t-test independent. The results showed that the utility of GD was 0.698 ¹ 0.22. The utility of anti-thyroid drug and radioactive iodine patient were 0.675 ¹ 0.23 and 0.754 ¹ 0.18 respectively. The utility of anti-thyroid drug was not significant different from the utility of radioactive iodine (p-value=0.07)
    corecore